Camp Lejeune cancer lawsuit

Certain Types Of Cancer May Be Presumed To Be Caused By Drinking Camp Lejeune Tap Water

Marines with cancer should consider the cause to be drinking contaminated Camp Lejeune tap water

Sunday, August 7, 2022 - It would be difficult to overestimate the scope and severity of the drinking water problem at Camp Lejeune Marine Corp Base. For almost half a century beginning around 1953, water wells at the base were known to be contaminated with with carcinogenic levels of VOCs, including PCE (perchloroethylene), a dry-cleaning solvent, and TCE (tricholoroethylene), an industrial degreaser putting hundreds of thousands of lives at risk. It is estimated that more than one million people may have been exposed to the poisonous chemicals in the Camp Lejeune water. Studies directly link TCE exposure with a higher incident rate of leukemia, a type of blood cancer effecting children. People who drank tap water at the base from 1953 to about 1987 are covered by the Camp Lejeune Justice Act and may be able to file lawsuits against the Federal government. All that is needed is the President's signature which is all but certain since he spoke of and promoted the Honoring Our Pact Act during his state of the Union Address to the American people earlier this year.

The types of Camp Lejeune cancer that marines and their families members may have have developed from drinking contamintated tap water is well documented. If you or a family member have developed or died from any of the following types of cancer, you may have a reason to file a Camp Lejeune cancer lawsuits. The types of cancer include but is not limited to: Adult leukemia; Aplastic anemia and other myelodysplastic syndromes; Bladder cancer; Kidney cancer; Liver cancer; Multiple myeloma; Non-Hodgkin's lymphoma, and also Parkinson's disease. Recently the Veterans Administration (VA) added nine rare types of cancer that may be presumed to have been caused by drinking toxic water. They are: Squamous cell carcinoma (SCC) of the larynx; SCC of the trachea; Adenocarcinoma of the trachea; Salivary gland-type tumors of the trachea; Adenosquamous carcinoma of the lung; Large cell carcinoma of the lung; Salivary gland-type tumors of the lung; Sarcomatoid carcinoma of the lung and; And typical and atypical carcinoid of the lung, according to the VA News web site.

To estimate the magnitude of the drinking water problem one must stop and think about the hundreds of ways we use ordinary tap drinking water in our lives and the lives of children who were most detrimentally affected by the contamination. Businesses, children in school, in daycare centers, and hospitals routinely drank contaminated Camp Lejeune drinking water. Many developed childhood leukemia and died at a young age, devastating the lives of their parents. Pregnant mothers that drank toxic drinking water may also have developed DNA damage that causes their offspring to be particularly susceptible to developing Camp Lejeune cancer. Marines stationed at Camp Lejeune with family members who have developed cancer or have died from the disease are encouraged to speak with a Camp Lejeune cancer attorney to start the wheels in motion to file a claim. There will be a limit in time to file a claim starting from the final presidential signage of the act so time is of the essence. For the record, civilians who worked at Camp Lejeune and their family members are also eligible to file for compensation.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.